The penetration of rifampin into human aqueous humor was determined in 15 patients undergoing elective cataract surgery. Between 0.9 and 5.5 h after administration of a single 600-mg oral dose, concentrations ranged from 6.0 to 21.5 mg/liter in serum and from <0.2 range of 0.2 to 3.2 mg/liter. Serum standards were prepared in pooled human serum, and the assay was linear over the range of 1.5 to 48.0 mg/liter. The interday coefficients of variation for both assays at high and low concentrations were <5%.
Bacterial endophthalmitis and corneal ulcers are among the most devastating of ocular infections (1) . Gram-positive cocci, especially Staphylococcus aureus and Staphylococcus epidennidis, are among the most common infecting organisms for both infections (3, 4) . Although rifampin is frequently used for serious staphylococcal infections, no data are available concerning the ocular penetration of the drug in humans. We measured the penetration of rifampin into aqueous humor in patients who had undergone elective cataract surgery following the administration of a single 600-mg oral dose.
Fifteen patients (ages, 65 to 87 years) scheduled to undergo elective cataract extraction participated in the study. The range of 0.2 to 3.2 mg/liter. Serum standards were prepared in pooled human serum, and the assay was linear over the range of 1.5 to 48.0 mg/liter. The interday coefficients of variation for both assays at high and low concentrations were <5%.
The results of the rifampin concentrations in serum and aqueous humor are shown in Table 1 and Fig. 1 . In only one patient (no. 9) was the concentration of rifampin in aqueous humor below the limit of assay sensitivity. For the remaining 14 patients, 2 to 9% of the corresponding rifampin concentrations in serum were achieved in the aqueous humor. No adverse reactions to rifampin were reported, and no patients developed endophthalmitis.
Concentrations of rifampin in aqueous humor following a single 600-mg oral dose ranged from less than 0.2 to 1.3 mg/liter in this study ( Table 1) . MICs of rifampin for both S. aureus and S. epidermidis are 0.004 to 0.015 mg/liter (5). Thus, even with the relatively low penetration ratios (aqueous humor/serum) observed in the absence of inflammation, rifampin levels in aqueous humor substantially exceed the MICs for these important pathogens. Furthermore, in pa- tients with ocular infections, we would expect the penetration ratio to increase.
Examination of Fig. 1 reveals the time dependency of the rifampin concentrations in serum and aqueous humor. Rifampin concentrations in aqueous humor steadily increased and seem to reach a peak within 3 to 4 h after dosing.
Regarding the treatment of staphylococcal endophthalmitis and corneal ulcers, orally administered rifampin provides aqueous humor concentrations which indicate that the drug should be a useful addition to antibiotic regimens. On the basis of these results, rifampin should be considered for the treatment of staphylococcal endophthalmitis and comeal ulcers. However, because of the propensity for the development of resistance to rifampin, it should not be employed alone but rather as part of a combination therapy for ocular infection.
